Bringing breakthrough regenerative medicine therapies to Minnesotans
Forecasted
Regenerative Medicine Minnesota funds research to develop and advance new regenerative medicine therapies and innovations for clinical use in Minnesota.
Funder: Regenerative Medicine Minnesota
Due Dates (Anticipated): November 2026 (Full application submission deadline, projected)
Funding Amounts: Up to $400,000 total ($200,000/year) for up to 2 years; higher requests require strong justification.
Summary: Supports development of novel regenerative medicine therapies or innovations that broadly enhance discovery, development, or delivery of regenerative medicine.
Key Information: Minnesota-based academic institutions and small businesses only; funds and work must remain in Minnesota.
Description
This opportunity from Regenerative Medicine Minnesota (RMM) funds projects that advance breakthrough regenerative medicine therapies or broadly applicable innovations to improve the field. The program seeks to position Minnesota as a leader in regenerative medicine by supporting projects that either:
- Develop novel regenerative medicine therapies and products with a clear target use, indication, or disease area for clinical application, or
- Foster innovations that enhance the discovery, development, or delivery of regenerative medicine therapies, with potential for broad application.
Eligible projects may include, but are not limited to: cell and gene therapies, tissue-engineered products, diagnostics, devices, platforms, processes, and enabling technologies. Activities can range from early feasibility studies to preclinical and clinical trial start-up, regulatory preparation, and development of tools or methods that facilitate progress in regenerative medicine.
